No amendment in the last 12 months on an offering that may still be open — Emergo Therapeutics, Inc. (latest filing May 9, 2022)
The latest filing for this offering is dated May 9, 2022 (first sale Apr 26, 2022). It reports $500,000 sold of $1,500,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
Sources
- Form D · May 9, 2022 ↗ (May 9, 2022)
- Emergo Therapeutics, Inc. — PartnerFacts page ↗ (May 9, 2022)